Ordering of Omics Features Using Beta Distributions on Montecarlo p-Values
暂无分享,去创建一个
Angela L. Riffo-Campos | Guillermo Ayala | J. Domingo | J. Domingo | A. Riffo-Campos | G. Ayala | Guillermo Ayala
[1] C. Moskaluk,et al. Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter , 2016, Oncogene.
[2] Hiroshi Tanaka,et al. Clinical Significance of Osteoprotegerin Expression in Human Colorectal Cancer , 2011, Clinical Cancer Research.
[3] Sheng Zhong,et al. Reproducibility Probability Score—incorporating measurement variability across laboratories for gene selection , 2006, Nature Biotechnology.
[4] Caixia Cheng,et al. Radiogenomic Analysis of F-18-Fluorodeoxyglucose Positron Emission Tomography and Gene Expression Data Elucidates the Epidemiological Complexity of Colorectal Cancer Landscape , 2019, Computational and structural biotechnology journal.
[5] W. Xue,et al. PRKAR2B promotes prostate cancer metastasis by activating Wnt/β‐catenin and inducing epithelial‐mesenchymal transition , 2018, Journal of cellular biochemistry.
[6] Gordon K Smyth,et al. Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.
[7] Michal A. Kurowski,et al. Transcriptome Profile of Human Colorectal Adenomas , 2007, Molecular Cancer Research.
[8] R. Sanz-Pamplona,et al. Colon-specific eQTL analysis to inform on functional SNPs , 2018, British Journal of Cancer.
[9] Z. Weng,et al. Analysis of Microarray and RNA-seq Expression Profiling Data. , 2017, Cold Spring Harbor protocols.
[10] Jing Li,et al. Differentially expressed lncRNAs and mRNAs identified by NGS analysis in colorectal cancer patients , 2018, Cancer medicine.
[11] R. Versteeg,et al. Mutations in the Ras–Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer , 2012, Clinical Cancer Research.
[12] Z. Jehan,et al. Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy. , 2011, The American journal of pathology.
[13] E. Vakiani,et al. Logarithmic expansion of LGR5+ cells in human colorectal cancer. , 2018, Cellular signalling.
[14] Hiroshi Tanaka,et al. Screening for epigenetically masked genes in colorectal cancer Using 5-Aza-2'-deoxycytidine, microarray and gene expression profile. , 2012, Cancer genomics & proteomics.
[15] D. Hu,et al. Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer , 2018, Bioscience reports.
[16] I. Mohamed Rose,et al. Genome-Wide Open Chromatin Methylome Profiles in Colorectal Cancer , 2020, Biomolecules.
[17] G. Smyth,et al. Statistical Applications in Genetics and Molecular Biology Permutation P -values Should Never Be Zero: Calculating Exact P -values When Permutations Are Randomly Drawn , 2011 .
[18] Claire Elayne Bangerter Owen. Parameter Estimation for the Beta Distribution , 2008 .
[19] A. Kalmár,et al. Dysplasia-Carcinoma Transition Specific Transcripts in Colonic Biopsy Samples , 2012, PloS one.
[20] Quan Chen,et al. Finding Genetic Overlaps Among Diseases Based on Ranked Gene Lists , 2015, J. Comput. Biol..
[21] Dong-Hyung Cho,et al. A nineteen gene‐based risk score classifier predicts prognosis of colorectal cancer patients , 2014, Molecular oncology.
[22] T. Triche,et al. Quantitative expression profiling in formalin-fixed paraffin-embedded samples by affymetrix microarrays. , 2010, The Journal of molecular diagnostics : JMD.
[23] Sean R. Davis,et al. NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..
[24] B. Molnár,et al. Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor , 2010, British Journal of Cancer.
[25] Eric Bair,et al. Identification of significant features in DNA microarray data , 2013, Wiley interdisciplinary reviews. Computational statistics.
[26] Caroline Mollevi,et al. Specific Extracellular Matrix Remodeling Signature of Colon Hepatic Metastases , 2013, PloS one.
[27] Thomas Downey,et al. A ‘metastasis-prone’ signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics , 2010, Clinical & Experimental Metastasis.
[28] Christian P. Robert,et al. Introducing Monte Carlo Methods with R , 2009 .
[29] Hiroshi Tanaka,et al. MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer , 2010, International journal of cancer.
[30] G. A. Barnard,et al. Discussion of Professor Bartlett''s paper , 1963 .
[31] D. Curran‐Everett,et al. The fickle P value generates irreproducible results , 2015, Nature Methods.
[32] Christopher D. Chambers,et al. Redefine statistical significance , 2017, Nature Human Behaviour.
[33] P. Delvenne,et al. Metastatic colorectal cancer cells maintain the TGFβ program and use TGFBI to fuel angiogenesis , 2021, Theranostics.
[34] Julie Goodman,et al. Germline variation in NCF4, an innate immunity gene, is associated with an increased risk of colorectal cancer , 2014, International journal of cancer.
[35] Krzysztof Goryca,et al. Modeling Oncogenic Signaling in Colon Tumors by Multidirectional Analyses of Microarray Data Directed for Maximization of Analytical Reliability , 2010, PloS one.
[36] Sampsa Hautaniemi,et al. Candidate driver genes in microsatellite‐unstable colorectal cancer , 2012, International journal of cancer.
[37] Anne-Laure Boulesteix,et al. Stability and aggregation of ranked gene lists , 2009, Briefings Bioinform..
[38] F. Wang,et al. Clinical correlation of B7-H3 and B3GALT4 with the prognosis of colorectal cancer , 2018, World journal of gastroenterology.